Delivery Order SPE2DB22D9316-SPE2DB25FYN72

Award Date 4/1/25
Potential Completion Date 4/22/25
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,526.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through November 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract with the DLA under the SPE2DB program to provide a broad range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,263.24 contract is for the supply of 4566770837 MITOSOL 0.2 MG KITS, with a period of performance through December 12, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,316.00 firm fixed-price contract is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through March 19, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,631.62 firm fixed-price delivery order is for the procurement of MITOSOL 0.2 MG KITS, with a contract period of performance ending on January 2, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,894.80 firm fixed-price delivery order is for the supply of 4565402048 MITOSOL 0.2 MG KITS, with a period of performance through August 26, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,263.24 firm fixed-price delivery order is for the supply of MITOSOL 0.2 MG KITS, with a period of performance through October 11, 2024. The award is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,263.24 firm fixed-price delivery order is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through January 15, 2025. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This federal contract award, valued at $10,526.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order (SPE2DB22D9309) for the supply of MITOSOL 0.8 MG Kits, with an ultimate completion date of August 2, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
This federal contract award, valued at $7,894.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of MITOSOL 0.2 MG KITS, a pharmaceutical product, with a completion date of May 9, 2023. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,158 contract is for the delivery of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through December 19, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYN72
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order valued at $6,579.00 for the supply of MITOSOL 0.2 MG KITS. The contract is a firm fixed-price agreement with an ultimate completion date of April 22, 2025.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items.

This contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 7/6/25, 12:43 AM